Wedbush Forecasts Increased Earnings for Vera Therapeutics
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Vera Therapeutics in a report issued on Tuesday, May 6th. Wedbush analyst L. Chico now forecasts that the company will post earnings of ($0.71) per share for the quarter, up from their prior estimate of ($0.73). […]
